![Peter B. Heifetz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter B. Heifetz
Director Ejecutivo en OrPro Therapeutics, Inc. .
Perfil
Peter B.
Heifetz is currently the President, Chief Executive Officer & Director at OrPro Therapeutics, Inc. and the Chief Scientific Officer at Rincon Pharmaceuticals, Inc. He holds graduate and doctorate degrees from Duke University.
Cargos activos de Peter B. Heifetz
Empresas | Cargo | Inicio |
---|---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Director Ejecutivo | - |
Formación de Peter B. Heifetz.
Duke University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter B. Heifetz